Fundamentals screen · refreshed after the Nov 12, 2026 close
Largest US companies: Healthcare
US-listed companies ranked by market capitalisation. Market capitalisation is shares outstanding multiplied by the latest close.
| # | Company | Price | Today | YTD | P/E | Mkt cap |
|---|---|---|---|---|---|---|
| 51 | NBIXNeurocrine BiosciencesHealthcare | $169.40 | −2.87% | +19.4% | 24.4× | $17.15B |
| 52 | EXELExelixisHealthcare | $69.84 | −1.22% | +59.3% | 19.3× | $17.04B |
| 53 | JAZZJazz PharmaceuticalsHealthcare | $240.37 | −3.17% | +41.4% | 74.9× | $15.43B |
| 54 | BBIOBridgeBio PharmaHealthcare | $78.17 | −1.72% | +2.2% | — | $15.23B |
| 55 | SOLVSolventumHealthcare | $88.81 | +0.21% | +12.1% | 96.8× | $15.09B |
| 56 | GKOSGlaukosHealthcare | $246.03 | −0.46% | +117.9% | — | $14.56B |
| 57 | BTSGBrightSpring Health ServicesHealthcare | $71.45 | −1.61% | +90.8% | 34.7× | $14.22B |
| 58 | EHCEncompass HealthHealthcare | $140.83 | −0.99% | +32.7% | 21.5× | $13.82B |
| 59 | BAXBaxter InternationalHealthcare | $25.74 | −2.28% | +34.7% | — | $13.32B |
| 60 | ELANElanco Animal Health IncorporatedHealthcare | $26.50 | +0.08% | +17.1% | — | $13.25B |
| 61 | PENPenumbraHealthcare | $320.77 | −0.30% | +3.2% | 80.5× | $12.64B |
| 62 | SMMTSummit TherapeuticsHealthcare | $15.08 | −9.40% | −13.8% | — | $12.06B |
| 63 | COOThe Cooper CompaniesHealthcare | $62.19 | −1.18% | −24.1% | 20.7× | $11.83B |
| 64 | ALGNAlign TechnologyHealthcare | $166.97 | −2.97% | +6.9% | 23.9× | $11.77B |
| 65 | HALOHalozyme TherapeuticsHealthcare | $100.67 | −0.99% | +49.6% | 23.6× | $11.48B |
| 66 | TECHBio-TechneHealthcare | $72.84 | +0.05% | +23.9% | 66.5× | $11.44B |
| 67 | UHSUniversal Health ServicesHealthcare | $193.84 | −1.49% | −11.1% | 7.6× | $11.18B |
| 68 | BMRNBioMarin PharmaceuticalsHealthcare | $56.70 | −2.79% | −4.6% | — | $10.98B |
| 69 | DVADaVitaHealthcare | $174.07 | −5.14% | +53.2% | 11.9× | $10.95B |
| 70 | ENSGThe Ensign GroupHealthcare | $186.55 | +0.19% | +7.1% | 27.3× | $10.88B |
| 71 | KYMRKymera TherapeuticsHealthcare | $127.17 | −5.69% | +63.4% | — | $10.86B |
| 72 | RGENRepligenHealthcare | $166.52 | −3.53% | +1.6% | — | $10.64B |
| 73 | AVTRAvantorHealthcare | $15.62 | −0.70% | +36.3% | 31.4× | $10.58B |
| 74 | BIO.BBio-Rad LaboratoriesHealthcare | $389.98 | +2.76% | — | 10.3× | $10.49B |
| 75 | PODDInsuletHealthcare | $149.29 | −0.49% | −47.5% | 24.2× | $10.36B |
| 76 | PCVXVaxcyteHealthcare | $64.69 | −5.73% | +40.2% | — | $10.24B |
| 77 | BIOBio-Rad LaboratoriesHealthcare | $370.48 | −4.02% | +22.3% | 9.7× | $9.96B |
| 78 | MDGLMadrigal PharmaceuticalsHealthcare | $425.21 | −1.81% | −27.0% | — | $9.88B |
| 79 | SYRESpyre TherapeuticsHealthcare | $102.91 | −3.66% | +214.1% | — | $9.77B |
| 80 | TGTXTG TherapeuticsHealthcare | $64.56 | −1.82% | +116.6% | 22.1× | $9.76B |
| 81 | GMEDGLOBUS MEDICALHealthcare | $72.30 | −4.10% | −17.2% | 17.2× | $9.59B |
| 82 | BRKRBrukerHealthcare | $60.33 | −3.33% | +28.1% | — | $9.21B |
| 83 | PRAXPraxis Precision MedicinesHealthcare | $324.76 | −6.20% | +10.2% | — | $9.08B |
| 84 | KRYSKrystal BiotechHealthcare | $305.68 | −1.01% | +24.0% | 40.2× | $9.06B |
| 85 | PTGXProtagonist TherapeuticsHealthcare | $134.38 | −0.36% | +53.9% | 25.6× | $8.77B |
| 86 | CORTCorcept TherapeuticsHealthcare | $73.71 | −1.10% | +111.8% | 49.2× | $7.97B |
| 87 | ALKSAlkermesHealthcare | $46.98 | −1.90% | +67.9% | — | $7.89B |
| 88 | CYTKCytokineticsHealthcare | $56.16 | −4.05% | −11.6% | — | $7.82B |
| 89 | TXG10x GenomicsHealthcare | $59.10 | −4.75% | +262.4% | — | $7.77B |
| 90 | PACSPACS GroupHealthcare | $48.00 | −4.12% | +25.0% | 27.4× | $7.62B |
| 91 | RYTMRhythm PharmaceuticalsHealthcare | $109.86 | −2.05% | +2.6% | — | $7.62B |
| 92 | AXSMAxsome TherapeuticsHealthcare | $144.37 | −3.26% | −21.0% | — | $7.59B |
| 93 | TWSTTwist BioscienceHealthcare | $114.22 | −6.83% | +260.1% | — | $7.57B |
| 94 | KNSAKiniksa Pharmaceuticals InternationalHealthcare | $96.28 | +0.54% | +133.4% | 69.0× | $7.56B |
| 95 | AMRXAmneal PharmaceuticalsHealthcare | $21.70 | −0.05% | +72.2% | 56.7× | $7.56B |
| 96 | BLCOBausch + LombHealthcare | $21.14 | −0.84% | +23.8% | — | $7.56B |
| 97 | IMVTImmunovantHealthcare | $35.05 | −5.37% | +37.9% | — | $7.25B |
| 98 | CHEChemedHealthcare | $550.20 | −0.08% | +28.6% | 25.2× | $7.13B |
| 99 | ORKAOruka TherapeuticsHealthcare | $104.99 | −2.03% | +246.4% | — | $7.12B |
| 100 | CAICaris Life SciencesHealthcare | $23.96 | −2.16% | −11.2% | 71.5× | $6.87B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.